title: [Conservative, palliative therapy of malignant pleural mesothelioma].
abstract: No effective conventional therapy for malignant pleural mesothelioma has yet been described. Radiotherapy does not increase median survival, but there is a palliative analgesic benefit. Chemotherapy with a different regimen in 182 patients led to a median survival time of 12 months. In comparison to an untreated historical group of 142 patients, there is an advantage in survival of 5 months. Additional surgical treatment has not prolonged the life expectancy. The percentage of long-time survivors was 5.5%.
authors.affiliation: AK Harburg, Lungenabteilung, Hamburg.
authors.forename: E
authors.initials: E
authors.lastname: Kaukel
authors.forename: G
authors.initials: G
authors.lastname: Koschel
authors.forename: P
authors.initials: P
authors.lastname: Schulz
mesh_terms: D000328:Adult; D000368:Aged; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D010997:Pleural Neoplasms / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate
vernacular_title: Konservative, palliative Therapie des malignen Pleuramesothelioms.